For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| RHA®4 With New Anesthetic Agent | Split-face injection of RHA®4 with new anesthetic agent in the nasolabial fold of one side of the face and RHA®4-Lidocaine in the nasolabial fold of opposite side of the face. | 0 | None | 0 | 30 | 5 | 30 | View |
| RHA®4-Lidocaine | Split-face injection of RHA®4 with new anesthetic agent in the nasolabial fold of one side of the face and RHA®4-Lidocaine in the nasolabial fold of opposite side of the face. | 0 | None | 0 | 30 | 4 | 30 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Injection site induration | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA | View |
| Injection site mass | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA | View |
| Injection site pruritus | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA | View |
| Paresthesia oral | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA | View |